(Q38134034)

29 August 2017

Extrahepatic complications of nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

29 August 2017

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002776%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ali Canbay

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002776%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Leon A Adams

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002776%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Wing-Kin Syn

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002776%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

English

0 references

publication date

16 January 2014

1 reference

29 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002776%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002776%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

1174-1197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002776%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002776%20AND%20SRC:MED&resulttype=core&format=json

Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

12 June 2020

cites work

1 reference

7 January 2021

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

1 reference

7 January 2021

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 reference

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

7 January 2021

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

7 January 2021

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

7 January 2021

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

1 reference

7 January 2021

Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?

1 reference

7 January 2021

Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults

1 reference

7 January 2021

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

1 reference

7 January 2021

Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment

1 reference

7 January 2021

Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver

1 reference

7 January 2021

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes

1 reference

7 January 2021

Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study

1 reference

7 January 2021

Carotid artery intima-media thickness in nonalcoholic fatty liver disease

1 reference

7 January 2021

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

1 reference

7 January 2021

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

1 reference

7 January 2021

Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people

1 reference

7 January 2021

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

1 reference

7 January 2021

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

1 reference

7 January 2021

Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population

1 reference

7 January 2021

Sonographic fatty liver, overweight and ischemic heart disease

1 reference

7 January 2021

Long term prognosis of fatty liver: risk of chronic liver disease and death.

1 reference

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

7 January 2021

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

7 January 2021

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

1 reference

7 January 2021

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

1 reference

7 January 2021

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

1 reference

7 January 2021

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.

1 reference

7 January 2021

Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study

1 reference

7 January 2021

Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study.

1 reference

7 January 2021

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

1 reference

7 January 2021

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

7 January 2021

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

1 reference

7 January 2021

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

1 reference

7 January 2021

Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

1 reference

7 January 2021

Gamma-glutamyltransferase and diabetes--a 4 year follow-up study

1 reference

7 January 2021

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

1 reference

7 January 2021

Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

7 January 2021

Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study

1 reference

7 January 2021

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease

1 reference

7 January 2021

NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study

1 reference

7 January 2021

Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006.

1 reference

7 January 2021

Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis

1 reference

7 January 2021

Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.

1 reference

7 January 2021

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes

1 reference

7 January 2021

Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes

1 reference

7 January 2021

Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup

1 reference

7 January 2021

Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study

1 reference

7 January 2021

Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults

1 reference

7 January 2021

Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men

1 reference

7 January 2021

The association of fatty liver and diabetes risk

1 reference

7 January 2021

Resolution of fatty liver and risk of incident diabetes

1 reference

7 January 2021

Chronic kidney disease in the developing world.

1 reference

7 January 2021

Early recognition and prevention of chronic kidney disease

1 reference

7 January 2021

Prevalence of chronic kidney disease in the United States

1 reference

7 January 2021

Prevalence and factors associated with CKD: a population study from Beijing

1 reference

7 January 2021

Projecting the number of patients with end-stage renal disease in the United States to the year 2015

1 reference

7 January 2021

Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans

1 reference

7 January 2021

Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease.

1 reference

7 January 2021

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis

1 reference

7 January 2021

Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis

1 reference

7 January 2021

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients

1 reference

7 January 2021

Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.

1 reference

7 January 2021

Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver

1 reference

7 January 2021

Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy.

1 reference

7 January 2021

Nonalcoholic steatohepatitis and increased risk of chronic kidney disease

1 reference

7 January 2021

Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994

1 reference

7 January 2021

Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population.

1 reference

7 January 2021

Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study

1 reference

7 January 2021

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk

1 reference

7 January 2021

gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men

1 reference

7 January 2021

Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.

1 reference

7 January 2021

Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease

1 reference

7 January 2021

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

7 January 2021

The metabolic syndrome and risk of incident colorectal cancer

1 reference

7 January 2021

Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men

1 reference

7 January 2021

Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study

1 reference

7 January 2021

Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.

1 reference

7 January 2021

Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia

1 reference

7 January 2021

Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps

1 reference

7 January 2021

High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis.

1 reference

7 January 2021

Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy

1 reference

7 January 2021

Non-alcoholic fatty liver disease in common endocrine disorders

1 reference

7 January 2021

Prevalence of hypothyroidism in nonalcoholic fatty liver disease

1 reference

7 January 2021

Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.

1 reference

7 January 2021

Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.

1 reference

7 January 2021

An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.

1 reference

7 January 2021

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction

1 reference

7 January 2021

Hepatic steatosis, GH deficiency and the effects of GH replacement: a Liverpool magnetic resonance spectroscopy study

1 reference

7 January 2021

Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men

1 reference

7 January 2021

Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients

1 reference

7 January 2021

Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy

1 reference

7 January 2021

Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease

1 reference

7 January 2021

Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study

1 reference

7 January 2021

Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis

1 reference

7 January 2021

Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance

1 reference

7 January 2021

Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women

1 reference

7 January 2021

Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese.

1 reference

7 January 2021

Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children

1 reference

7 January 2021

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

1 reference

7 January 2021

The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome

1 reference

7 January 2021

Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications.

1 reference

7 January 2021

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver

1 reference

7 January 2021

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

1 reference

7 January 2021

Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease.

1 reference

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

7 January 2021

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

1 reference

7 January 2021

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

1 reference

7 January 2021

AASLD practice guidelines: Evaluation of the patient for liver transplantation

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26717

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002776%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference